Insights from BCC Research

Universal Flu Vaccines: What Are the Chances?

Posted by BCC Research Editorial on Apr 27, 2018 9:05:00 AM

 

Universal_Flue_Vaccine

With each flu season comes a new flu vaccine, but could this cycle be broken? According to a recent article in Scientific American, scientists are moving closer to a universal flu vaccine. Researchers at the University of Southern California are departing from the traditional vaccine, which relies on a cocktail consisting of several strains of killed virus.

“The new vaccine, by contrast, uses a live virus, so it elicits both an antibody response and T cell immunity—at least in lab ferrets and mice,” the article notes.

Read More

Topics: Life Sciences

Studies Find Non-Opioid Meds as Effective for Pain Relief as Opioids

Posted by Clayton Luz on Mar 29, 2018 10:00:00 AM

NonOpioid PainTreatment Drugs

In 2016, 116 people died every day from opioid-related drug overdoses, according to the U.S. Department of Health and Services. Opioid-involved deaths are continuing to increase in the United States. More than three out of five drug overdose deaths involve an opioid.

Read More

Topics: Healthcare, Life Sciences

Patent Cliff Paves the Way for Biosimilars to Disrupt Market

Posted by Jeff Schmerker on Mar 26, 2018 10:30:00 AM

Biological SafetyTesting.jpgThe global market for biological safety testing is anticipating brisk growth in coming years owing to the growth of personalized medicines, patent expiration of brand-name biologics, and the development of new cell lines that express specific biomarkers for disease states, according to a new report from BCC Research. The market’s compound annual growth rate (CAGR) is forecast to be 20.09% through 2022.

Read More

Topics: Biotechnology, Life Sciences

Computational Approaches Opening New Frontiers in Drug Discovery

Posted by Laurie L. Sullivan on Feb 26, 2018 11:00:00 AM

Drug Discovery.jpegGlobally, the rise in research expenditures, deterioration in human health conditions and the need for novel and effective therapies have boosted the demand for drug discovery tools. In just the last few years, the drug discovery and development industry has undergone a major transition, with increased calls for efficient, user-friendly and affordable products. A new study by BCC Research examines all aspects of the drug discovery process, which consumes a major portion of drug development costs. Therefore, it is imperative for companies to use technologies that offer a high probability that their future drug product will be commercially successful.

Read More

Topics: Biotechnology, Life Sciences